PNPLA2 and fatty liver disease: ShRNA knockdown or genetic ablation of hepatic ATGL promoted progressive hepatic steatosis and enhanced lipid droplet (LD) accumulation (Ong et al., 2011; Wu et al., 2012), while overexpression of ATGL in the liver alleviated steatosis (Turpin et al., 2011).